Literature DB >> 8358552

Roles of prostacyclin, EDRF and active oxygens in leukocyte-dependent platelet adhesion to endothelial cells induced by platelet-activating factor in vitro.

M Hirafuji1, H Shinoda.   

Abstract

1. The mechanism of polymorphonuclear leukocyte (PMN)-dependent platelet adhesion to cultured endothelial cells induced by platelet-activating factor (PAF) was investigated to determine whether PMNs release or generate any factor(s) capable of inducing platelet adhesion, and the roles of prostacyclin and endothelium-derived relaxing factor (EDRF). 2. Cell-free supernatants, sonicates or rapid filtrates of PAF-stimulated PMN suspensions did not induce platelet adhesion to endothelial cells, but the PMN sonicates induced platelet adhesion when endothelial cells were pretreated with both aspirin and NG-nitro-L-arginine (L-NOARG). Its microphotograph showed that mainly platelet aggregates adhered to the endothelial cell surface. 3. Platelet adhesion induced by the PMN sonicates to aspirin- and L-NOARG-pretreated endothelial cells was dose-dependently prevented by OP-41483 (1-100 nM), and slightly by L-arginine (1 mM). The inhibition of platelet adhesion by OP-41483 and L-arginine was potentiated by their combination. 4. WEB 2170 (3 microM), a PAF antagonist, inhibited platelet adhesion induced by the PMN sonicates. However, PAF alone did not induce significant platelet adhesion to aspirin- and L-NOARG-treated endothelial cells. 5. Platelet adhesion induced by the PMN sonicates was not suppressed by AA-861 and indomethacin. However, both superoxide dismutase and catalase significantly inhibited platelet adhesion, and, in combination, their inhibitory effect was synergistically potentiated. Mannitol had no effect. It was also significantly inhibited by alpha 1-antitrypsin, whereas chymostatin and elastatinal had no effect. 6. PAF-induced platelet adhesion to endothelial cells in the presence of intact PMNs was not suppressed by indomethacin and AA-861, or by protease inhibitors. SOD alone, and in combination with catalase, caused a slight but significant inhibition, while catalase and mannitol by themselves had no effect.7. PMN-induced platelet adhesion was slightly inhibited by OP-41483 (100 nM). L-Arginine (1 mM)alone had no effect, but slightly potentiated the effect of OP-41483. This platelet adhesion was not accompanied by suppression of prostacyclin synthesis.8. The results with the PMN sonicates show that prostacyclin, EDRF and active oxygens are important modulators of intercellular interactions between platelets and endothelial cells. These results further suggest that the mechanism of intact PMN-dependent platelet adhesion is primarily through platelet endothelial cell interactions in which leukocyte-derived active oxygens play a role, but does not involve platelet-platelet interactions inhibitable by prostacyclin.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8358552      PMCID: PMC2175688          DOI: 10.1111/j.1476-5381.1993.tb13601.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  21 in total

1.  The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium.

Authors:  M W Radomski; R M Palmer; S Moncada
Journal:  Biochem Biophys Res Commun       Date:  1987-11-13       Impact factor: 3.575

2.  Neutrophils adherent to a nonphagocytosable surface (glomerular basement membrane) produce oxidants only at the site of attachment.

Authors:  M C Vissers; W A Day; C C Winterbourn
Journal:  Blood       Date:  1985-07       Impact factor: 22.113

3.  Endothelium-dependent inhibition of platelet aggregation.

Authors:  H Azuma; M Ishikawa; S Sekizaki
Journal:  Br J Pharmacol       Date:  1986-06       Impact factor: 8.739

4.  Endothelium-derived relaxing factor inhibits in vitro platelet aggregation.

Authors:  B Furlong; A H Henderson; M J Lewis; J A Smith
Journal:  Br J Pharmacol       Date:  1987-04       Impact factor: 8.739

Review 5.  Consequences of leukocyte-vessel wall interactions in inflammatory and immune reactions.

Authors:  J M Harlan
Journal:  Semin Thromb Hemost       Date:  1987-10       Impact factor: 4.180

6.  The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide.

Authors:  M W Radomski; R M Palmer; S Moncada
Journal:  Br J Pharmacol       Date:  1987-11       Impact factor: 8.739

7.  An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation.

Authors:  S Moncada; R Gryglewski; S Bunting; J R Vane
Journal:  Nature       Date:  1976-10-21       Impact factor: 49.962

8.  Pharmacological profile of AA-861, a 5-lipoxygenase inhibitor.

Authors:  Y Ashida; T Saijo; H Kuriki; H Makino; S Terao; Y Maki
Journal:  Prostaglandins       Date:  1983-12

9.  Platelet adhesion to cultured vascular endothelial cells. A quantitative monolayer adhesion assay.

Authors:  K D Curwen; H Y Kim; M Vazquez; R I Handin; M A Gimbrone
Journal:  J Lab Clin Med       Date:  1982-09

10.  Antagonism of platelet-activating factor-induced increase in cytosolic free calcium concentration in human endothelial cells.

Authors:  M Hirafuji; H Shinoda
Journal:  Jpn J Pharmacol       Date:  1992-03
View more
  1 in total

1.  Involvement of platelet cyclic GMP but not cyclic AMP suppression in leukocyte-dependent platelet adhesion to endothelial cells induced by platelet-activating factor in vitro.

Authors:  M Hirafuji; A Nezu; H Shinoda; M Minami
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.